Listen to Story The nasal spray vaccine has been approved to fight against flu diseases FluMist is the first vaccine to ...
The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.
The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self-administered ...
The FDA stated in a release that, "The most commonly reported side-effects of FluMist are fever over 100°F in children 2 ...
· FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider. · FluMist ...
It’s goodbye needles as you can keep the flu away with a nasal spray as the US Food and Drug Administration (FDA) has approved AstraZeneca’s FluMist for home use. It can be self-administered by adults ...
FluMist will also continue to be available at doctors’ offices and pharmacies. For children between 2 and 17, the FDA recommends that a caregiver give the spray. Common side effects include a runny or ...